Literature DB >> 6424035

Release of prostacyclin from the human pulmonary vascular bed in response to cholinergic stimulation.

R Brandt, A Dembińska-Kieć, R Korbut, R J Gryglewski, J Nowak.   

Abstract

The ability of the human pulmonary vascular bed to synthesize prostaglandins (PGs) in response to cholinergic stimulation was investigated in healthy male volunteers. In all of them, except controls, carbaminoylcholine (CCh) was injected subcutaneously at a dose of 5 micrograms/kg. In 3 subjects [1-14C]-labelled arachidonate was then infused at a constant rate into the right atrium between 10 and 15 min after the administration of the drug and the blood from the subclavian artery was sampled simultaneously. The arterial content of [14C]-labelled metabolites was extracted, separated by thin-layer chromatography and quantified using liquid scintillation spectrometry. In 8 other subjects PGI2-like activity after the administration of CCh was assayed in the arterial blood and in 1 subject in the venous blood, using a technique for continuous measurement of platelet aggregation on blood-superfused collagen strip. The major portion of [14C]-activity in the radiochromatograms migrated in parallel with the 6-keto-PGF1 alpha standard. No early defined peaks corresponding to any of the unlabelled PGs D2, E2 or F2 alpha, appeared, but in one chromatogram a minor radiopeak corresponding to authentic thromboxane B2 was observed. Also in the platelet aggregation experiments, 5-15 min after the administration of CCh, a significant increase in the PGI2-like activity was observed in the arterial as well as in the peripheral venous blood, which effect of the drug was abolished by pretreatment with atropine and acetylsalicylic acid.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6424035     DOI: 10.1007/bf00507056

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  30 in total

1.  Differential inhibition of prostacyclin production and platelet aggregation by aspirin.

Authors:  G Masotti; G Galanti; L Poggesi; R Abbate; G G Neri Serneri
Journal:  Lancet       Date:  1979-12-08       Impact factor: 79.321

2.  Lungs as a generator of prostacyclin--hypothesis on physiological significance.

Authors:  R J Gryglewski; R Korbut; A Ocetkiewicz; J Spławiński; B Wojtaszek; J Swies
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-08       Impact factor: 3.000

3.  Prostacyclin is a circulating hormone.

Authors:  S Moncada; R Korbut; S Bunting; J R Vane
Journal:  Nature       Date:  1978-06-29       Impact factor: 49.962

4.  Reversal of platelet aggregation by prostacyclin.

Authors:  R J Gryglewski; R Korbut; A Ocetkiewicz
Journal:  Pharmacol Res Commun       Date:  1978-02

5.  Duration of inhibition of platelet prostaglandin formation and aggregation by ingested aspirin or indomethacin.

Authors:  J J Kocsis; J Hernandovich; M J Silver; J B Smith; C Ingerman
Journal:  Prostaglandins       Date:  1973-02

6.  Inhibition of prostaglandin synthesis in man.

Authors:  M Hamberg
Journal:  Biochem Biophys Res Commun       Date:  1972-11-01       Impact factor: 3.575

7.  Prostaglandin synthesis in human skeletal muscle and kidney microsomes: formation of substantial amounts of an unknown, polar compound.

Authors:  J Nowak; S O Bohman; T Berlin; T Sonnenfeld
Journal:  Acta Physiol Scand       Date:  1981-12

8.  Acetylation of prostaglandin synthase by aspirin.

Authors:  G J Roth; N Stanford; P W Majerus
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

9.  Acetylation of the NH2-terminal serine of prostaglandin synthetase by aspirin.

Authors:  G J Roth; C J Siok
Journal:  J Biol Chem       Date:  1978-06-10       Impact factor: 5.157

10.  Prostacyclin is not a circulating hormone.

Authors:  E Christ-Hazelhof; D H Nugteren
Journal:  Prostaglandins       Date:  1981-11
View more
  3 in total

Review 1.  Physiology and pharmacology of prostaglandins.

Authors:  S J Konturek; W Pawlik
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

2.  Effects of indomethacin on muscarinic inhibition of endogenous noradrenaline release from rat isolated trachea.

Authors:  K Racké; G Brunn; M Elsner; I Wessler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-07       Impact factor: 3.000

3.  Aging-shifted prostaglandin profile in endothelium as a factor in cardiovascular disorders.

Authors:  Hao Qian; Na Luo; Yuling Chi
Journal:  J Aging Res       Date:  2012-02-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.